Disability Resource Directory

Parkinson's Disease

 


Parkinson's Disease Information

 The onset of Parkinson's disease is a tragic time for any patient and their families. As a degenerative condition, patients suffering from the condition are faced with no hope of recovery, but rather a slow and wearing process of loss of movement and co-ordination. Most notably, the condition involves the tremor, whereby patients can be seen trembling uncontrollably, as well as loss in speech capabilities and gradually all functionality in its later stages.

Parkinson's disease is a disorder which takes effect on the central nervous system. A movement disorder, Parkinson's can be seen in four major symptoms; namely rigidity of muscles, a tremor of movement, slowing of overall movement (known as bradykinesia) and in certain instances loss of movement altogether. The symptoms gradually become more and more apparent in sufferers, and are progressive, that is patients do not recover, or get better. This degenerative condition is not contagious, nor passed genetically, and unfortunately very little is known about the causes of most instances of the condition. Having said that, some cases can be explained through extreme drug ...
[Read more...]

 

More articles on Parkinson's disease

 

Parkinson's disease news on the Web

With new 'AO' rule out, VA readies spigot of payments - Stars and Stripes

View Original Article Fri, 03 Sep 2010 13:24:06 GMT+00:00

Washington Post

With new 'AO' rule out, VA readies spigot of payments
Stars and Stripes
31 for compensating Vietnam veterans with ischemic heart disease, Parkinson's disease or B-cell leukemia, or their surviving spouses. ...
VA expands its list of Agent Orange illsTimes Herald-Record
VA Sets New Benefit Rules for Agent Orange-Related IlnessesLawyers and Settlements
If it can happen in the US, why not Canada?Daily Gleaner
Washington Post -InfoCuts (blog) -The Associated Press
all 660 news articles »

Santhera Pharmaceuticals Holding AG: Santhera and Ipsen Enter into Licensing ... - Reuters (press release)

View Original Article Fri, 03 Sep 2010 06:01:26 GMT+00:00

Santhera Pharmaceuticals Holding AG: Santhera and Ipsen Enter into Licensing ...
Reuters (press release)
This first-in-class compound is currently under investigation for the treatment of levodopa-induced dyskinesia in Parkinson's Disease. ...
Santhera Reports 2010 Interim Financial Results with Significant Reduction in ...MarketWatch
Ipsen, Santhera Agree On Fipamezole License Outside North America, JapanAutomated Trader
Santhera, Ipsen ink fipamezole pactFierceBiotech

all 23 news articles »

Pfizer Agrees To Buy FoldRx in Rare-Disease Treatment Expansion Effort - Bloomberg

View Original Article Wed, 01 Sep 2010 15:23:29 GMT+00:00

Star Global Tribune (blog)

Pfizer Agrees To Buy FoldRx in Rare-Disease Treatment Expansion Effort
Bloomberg
FoldRx is also working on drugs in earlier stages of testing for Parkinson's disease, Huntington's disease, cystic fibrosis, and a rare heart condition ...
Pfizer To Acquire FoldRx PharmaceuticalsPharmaceuticals & Healthcare Insight (registration)
Pfizer to Acquire FoldRx PharmaceuticalsPR Newswire (press release)
Pfizer Picking Up FoldRx in Latest Rare Disease BuyoutBioWorld Online
Genetic Engineering News
all 201 news articles »

Verna?s Victory

View Original Article Wed, 01 Sep 2010 08:09:14 -0700
THESE days it is fashionable to celebrate the life of someone who has died, unlike in the past where we just mourned that person?s death. Well and good, it is mentally healthier to do so.

Research and Markets: Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts ...

View Original Article Wed, 01 Sep 2010 09:00:00 -0700
DUBLIN----Research and Markets has announced the addition of GlobalData 's new report "Neurostimulation Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" to their offering.

NIH Issues New Stem Cell Research Guidelines as Obama Administration Prepares to Appeal Court Ruling

View Original Article Tue, 31 Aug 2010 07:58:51 -0700
The National Institutes of Health (NIH) -- still reeling from a District Court ruling that blocked the use of federal funds for embryonic cell research -- issued new guidance last night detailing how it will comply with the Court's preliminary injunction. National Institutes of Health - Injunction - District Court - Stem cell - Research